Company Filing History:
Years Active: 2017-2022
Title: **The Innovative Mind of Franz Groiss**
Introduction
Franz Groiss, a prolific inventor based in Langenzersdorf, Austria, has made significant contributions to the field of cancer treatment. With a focus on innovative methodologies, Groiss holds two patents that exemplify his commitment to advancing medical science.
Latest Patents
Groiss’ most notable inventions pertain to methodologies for treating GD2 positive cancer. His first patent details a novel approach where a preparation consisting of an anti-GD2 antibody is administered to patients as a continuous intravenous infusion over 24 hours per day. This groundbreaking method aims to enhance the efficacy of cancer treatment for patients suffering from this specific type of malignancy.
Career Highlights
Throughout his career, Franz Groiss has been associated with Apeiron Biologics AG, a company recognized for its pioneering efforts in immunotherapy. His work at Apeiron has placed him at the forefront of innovative biomedical research aimed at combating cancer.
Collaborations
In addition to his individual contributions, Groiss collaborates closely with esteemed colleagues, including Hans Loibner and Manfred Schuster. Together, they form a talented team dedicated to fostering advancements in therapeutic approaches and transforming patient care.
Conclusion
Franz Groiss stands out as an influential figure in the realm of cancer treatment innovations. His patents reflect a deep understanding of medical challenges and a determination to develop effective solutions. As the fight against cancer continues, inventors like Groiss play an essential role in shaping the future of medicine.